☰

Yang Lei, Ph.D. - Publications

Affiliations: 
2014 Bioengineering Clemson University, Clemson, SC, United States 
Area:
Biomedical
Tree Info Similar researchers PubMed Report error

17 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2021 Lan X, Zhao Q, Zhang J, Lei Y, Wang Y. A combination of hydrogen bonding and chemical covalent crosslinking to fabricate a novel swim-bladder-derived dry heart valve material yields advantageous mechanical and biological properties. Biomedical Materials (Bristol, England). 16: 015014. PMID 33586662 DOI: 10.1088/1748-605X/Abb616  0.332
2020 Kuang D, Lei Y, Yang L, Wang Y. Preclinical study of a self-expanding pulmonary valve for the treatment of pulmonary valve disease. Regenerative Biomaterials. 7: 609-618. PMID 33365146 DOI: 10.1093/Rb/Rbaa035  0.313
2020 Yang L, Huang X, Deng L, Ma X, Jiang H, Ning Q, Liang Z, Lei Y, Wang Y. Pre-mounted dry TAVI valve with improved endothelialization potential using REDV-loaded PEGMA hydrogel hybrid pericardium. Journal of Materials Chemistry. B. PMID 32149310 DOI: 10.1039/C9Tb00879A  0.349
2019 Jin L, Guo G, Jin W, Lei Y, Wang Y. Cross-Linking Methacrylated Porcine Pericardium by Radical Polymerization Confers Enhanced Extracellular Matrix Stability, Reduced Calcification, and Mitigated Immune Response to Bioprosthetic Heart Valves Acs Biomaterials Science & Engineering. 5: 1822-1832. PMID 33405556 DOI: 10.1021/Acsbiomaterials.9B00091  0.306
2019 Guo G, Jin W, Jin L, Chen L, Lei Y, Wang Y. Hydrogel hybrid porcine pericardium for the fabrication of a pre-mounted TAVI valve with improved biocompatibility. Journal of Materials Chemistry. B. 7: 1427-1434. PMID 32255013 DOI: 10.1039/C8Tb02565G  0.344
2019 Lei Y, Deng L, Tang Y, Ning Q, Lan X, Wang Y. Hybrid Pericardium with VEGF-Loaded Hyaluronic Acid Hydrogel Coating to Improve the Biological Properties of Bioprosthetic Heart Valves. Macromolecular Bioscience. e1800390. PMID 30951253 DOI: 10.1002/Mabi.201800390  0.331
2019 Lei Y, Ning Q, Tang Y, Wang Y. Exogenous hyaluronic acid and chondroitin sulfate crosslinking treatment for increasing the amount and stability of glycosaminoglycans in bioprosthetic heart valves. Journal of Materials Science. Materials in Medicine. 30: 38. PMID 30840150 DOI: 10.1007/S10856-019-6237-7  0.322
2019 Lei Y, Guo G, Jin W, Liu M, Wang Y. Riboflavin photo-cross-linking method for improving elastin stability and reducing calcification in bioprosthetic heart valves. Xenotransplantation. e12481. PMID 30609151 DOI: 10.1111/Xen.12481  0.304
2019 Hu Y, Su X, Lei Y, Wang Y. A novel anti-calcification method for bioprosthetic heart valves using dopamine-modified alginate Polymer Bulletin. 76: 1423-1434. DOI: 10.1007/S00289-018-2450-7  0.322
2018 Guo G, Jin L, Jin W, Chen L, Lei Y, Wang Y. Radical polymerization-crosslinking method for improving extracellular matrix stability in bioprosthetic heart valves with reduced potential for calcification and inflammatory response. Acta Biomaterialia. PMID 30326277 DOI: 10.1016/J.Actbio.2018.10.017  0.353
2018 Lei Y, Yang L, Guo G, Wang Y. EGCG and enzymatic cross-linking combined treatments for improving elastin stability and reducing calcification in bioprosthetic heart valves. Journal of Biomedical Materials Research. Part B, Applied Biomaterials. PMID 30267643 DOI: 10.1002/Jbm.B.34247  0.3
2018 Jin W, Guo G, Chen L, Lei Y, Wang Y. Elastin Stabilization Through Polyphenol and Ferric Chloride Combined Treatment for the Enhancement of Bioprosthetic Heart Valve Anticalcification. Artificial Organs. PMID 30058211 DOI: 10.1111/Aor.13151  0.341
2015 Lei Y, Iwashita M, Choi J, Aikawa M, Aikawa E. N-acetylglucosamine-1-Phosphate Transferase Suppresses Lysosomal Hydrolases in Dysfunctional Osteoclasts: A Potential Mechanism for Vascular Calcification. Journal of Cardiovascular Development and Disease. 2: 31-47. PMID 29371511 DOI: 10.3390/Jcdd2020031  0.311
2014 Lei Y, Nosoudi N, Vyavahare N. Targeted chelation therapy with EDTA-loaded albumin nanoparticles regresses arterial calcification without causing systemic side effects. Journal of Controlled Release : Official Journal of the Controlled Release Society. 196: 79-86. PMID 25285609 DOI: 10.1016/J.Jconrel.2014.09.029  0.573
2014 Sinha A, Shaporev A, Nosoudi N, Lei Y, Vertegel A, Lessner S, Vyavahare N. Nanoparticle targeting to diseased vasculature for imaging and therapy. Nanomedicine : Nanotechnology, Biology, and Medicine. 10: 1003-12. PMID 24566276 DOI: 10.1016/J.Nano.2014.02.002  0.628
2014 Lei Y, Sinha A, Nosoudi N, Grover A, Vyavahare N. Hydroxyapatite and calcified elastin induce osteoblast-like differentiation in rat aortic smooth muscle cells. Experimental Cell Research. 323: 198-208. PMID 24447384 DOI: 10.1016/J.Yexcr.2014.01.011  0.612
2013 Lei Y, Grover A, Sinha A, Vyavahare N. Efficacy of reversal of aortic calcification by chelating agents. Calcified Tissue International. 93: 426-35. PMID 23963635 DOI: 10.1007/S00223-013-9780-0  0.633
Show low-probability matches.